Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07469540

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Jérôme Bouchan · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to determine whether an aerobic exercise program can reduce cardiovascular risk in patients with systemic inflammation, such as those with rheumatoid arthritis and chronic kidney disease. The main questions this study aims to address are: * Does an individualized aerobic exercise program reduce cardiovascular risk, as assessed arterial stiffness and endothelial function ? * What are the effects of this exercise program on inflammation and immunosenescence? Researchers will compare an individualized aerobic exercise program with a therapeutic education program (consisting of educational phone calls only) and a control group with no intervention. Participants will: * Perform three physical activity sessions per week for six weeks (45-minute sessions at 60-80% of heart rate reserve); * Attend clinic visits at baseline, after the 6-week intervention, and at a 6-week follow-up after the intervention; * Undergo assessments including pulse wave velocity, hyperemic reactivity, and blood analyses.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAerobic exercise programAerobic exercise program during 6 weeks, with 3 sessions / week. Each session includes 45 minutes of ergocycle, with 9 cycles of 4 minutes at 60% of heart rate and 1 minute at 80%.
BEHAVIORALTherapeutic educationTherapeutic education for 6 weeks, with one telephone call per week. Each call includes advices and exchanges to improve physical activity level.

Timeline

Start date
2026-03-16
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-03-13
Last updated
2026-03-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07469540. Inclusion in this directory is not an endorsement.